PortfoliosLab logoPortfoliosLab logo
FBT vs. XPH
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

FBT vs. XPH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in First Trust Amex Biotechnology Index (FBT) and SPDR S&P Pharmaceuticals ETF (XPH). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, FBT achieves a 18.66% return, which is significantly lower than XPH's 21.77% return. Over the past 10 years, FBT has outperformed XPH with an annualized return of 9.39%, while XPH has yielded a comparatively lower 4.97% annualized return.


FBT

1D
-3.01%
1M
-4.04%
6M
15.09%
YTD
18.66%
1Y
49.10%
3Y*
17.01%
5Y*
8.29%
10Y*
9.39%
ALL TIME*
13.46%

XPH

1D
-2.41%
1M
1.34%
6M
23.05%
YTD
21.77%
1Y
64.21%
3Y*
17.71%
5Y*
7.57%
10Y*
4.97%
ALL TIME*
9.38%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$41.36M$24.77M$18.75M
$6.19M$7.25M$5.32M

FBT vs. XPH - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
FBT
First Trust Amex Biotechnology Index
18.66%24.25%5.88%2.55%-4.83%-2.26%12.96%19.74%-0.30%37.07%
XPH
SPDR S&P Pharmaceuticals ETF
21.77%31.60%4.94%2.97%-9.83%-10.54%14.68%25.61%-15.32%12.05%

Correlation

The correlation between FBT and XPH is 0.71, which is moderate. They have sometimes moved together and sometimes differently, sharing some price drivers without tracking each other closely.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.71

Correlation (3Y)
Balances recent behavior with more history.

0.74

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.77

Correlation (10Y)
Provides a long-term view across more market conditions.

0.77

Correlation (All Time)
Calculated using the full available price history since Jun 23, 2006

0.76

The correlation between FBT and XPH has been stable across timeframes, ranging from 0.71 to 0.77 - a consistent structural relationship.

FBT vs. XPH - Sectors Allocation Comparison


Sectors
FBT
XPH

Healthcare

100.0%
100.0%

Basic Materials

-

-

Communication Services

-

-

Consumer Cyclical

-

-

Consumer Defensive

-

-

Energy

-

-

Financial Services

-

-

Industrials

-

-

Real Estate

-

-

Technology

-

-

Utilities

-

-

Healthcare

FBT
100.0%
XPH
100.0%

Basic Materials

FBT

-

XPH

-

Communication Services

FBT

-

XPH

-

Consumer Cyclical

FBT

-

XPH

-

Consumer Defensive

FBT

-

XPH

-

Energy

FBT

-

XPH

-

Financial Services

FBT

-

XPH

-

Industrials

FBT

-

XPH

-

Real Estate

FBT

-

XPH

-

Technology

FBT

-

XPH

-

Utilities

FBT

-

XPH

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

FBT vs. XPH — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

FBT
FBT Risk / Return Rank: 8787
Overall Rank
FBT Sharpe Ratio Rank: 9191
Sharpe Ratio Rank
FBT Sortino Ratio Rank: 9191
Sortino Ratio Rank
FBT Omega Ratio Rank: 8888
Omega Ratio Rank
FBT Calmar Ratio Rank: 8787
Calmar Ratio Rank
FBT Martin Ratio Rank: 7979
Martin Ratio Rank

XPH
XPH Risk / Return Rank: 9595
Overall Rank
XPH Sharpe Ratio Rank: 9696
Sharpe Ratio Rank
XPH Sortino Ratio Rank: 9595
Sortino Ratio Rank
XPH Omega Ratio Rank: 9393
Omega Ratio Rank
XPH Calmar Ratio Rank: 9595
Calmar Ratio Rank
XPH Martin Ratio Rank: 9595
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

FBT vs. XPH - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for First Trust Amex Biotechnology Index (FBT) and SPDR S&P Pharmaceuticals ETF (XPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


FBTXPHDifference
Sharpe ratioReturn per unit of total volatility

-0.64

Sortino ratioReturn per unit of downside risk

-0.61

Omega ratioGain probability vs. loss probability

1.39

1.47

-0.07

Calmar ratioReturn relative to maximum drawdown

3.47

5.57

-2.10

Martin ratioReturn relative to average drawdown

10.25

19.83

-9.58

FBT vs. XPH - Sharpe Ratio Comparison

The current FBT Sharpe Ratio is 2.31, which is comparable to the XPH Sharpe Ratio of 2.95. The chart below compares the historical Sharpe Ratios of FBT and XPH, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

FBT vs. XPH - Drawdown Comparison

The maximum FBT drawdown since its inception was -40.51%, smaller than the maximum XPH drawdown of -48.03%. Use the drawdown chart below to compare losses from any high point for FBT and XPH.


Loading charts...

Drawdown Indicators


FBTXPHDifference

Max Drawdown

Largest peak-to-trough decline

-40.51%

-48.03%

+7.52%

Max Drawdown (1Y)

Largest decline over 1 year

-14.26%

-11.97%

-2.29%

Max Drawdown (3Y)

Largest decline over 3 years

-20.05%

-23.57%

+3.52%

Max Drawdown (5Y)

Largest decline over 5 years

-28.98%

-30.92%

+1.94%

Max Drawdown (10Y)

Largest decline over 10 years

-32.37%

-35.97%

+3.60%

Current Drawdown

Current decline from peak

-4.34%

-2.84%

-1.50%

Average Drawdown

Average peak-to-trough decline

-11.09%

-17.13%

+6.04%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.81%

3.35%

+1.46%

Volatility

FBT vs. XPH - Volatility Comparison

The current volatility for First Trust Amex Biotechnology Index (FBT) is 6.29%, while SPDR S&P Pharmaceuticals ETF (XPH) has a volatility of 8.09%. This indicates that FBT experiences smaller price fluctuations and is considered to be less risky than XPH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


FBTXPHDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.29%

8.09%

-1.80%

Volatility (6M)

Calculated over the trailing 6-month period

16.08%

17.55%

-1.47%

Volatility (1Y)

Calculated over the trailing 1-year period

21.41%

22.68%

-1.27%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

22.01%

21.02%

+0.99%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

23.77%

22.13%

+1.64%

FBT vs. XPH - Expense Ratio Comparison

FBT has a 0.57% expense ratio, which is higher than XPH's 0.35% expense ratio.


Dividends

FBT vs. XPH - Dividend Comparison

FBT has not paid dividends to shareholders, while XPH's dividend yield for the trailing twelve months is around 0.49%.


PositionTTM20252024202320222021202020192018201720162015
FBT
First Trust Amex Biotechnology Index
0.00%0.00%0.71%0.00%0.00%1.37%0.00%0.00%0.00%0.00%0.00%0.12%
XPH
SPDR S&P Pharmaceuticals ETF
0.49%0.83%1.58%1.28%1.64%0.95%0.47%0.64%0.65%0.67%0.63%7.15%

Frequently Asked Questions


FBT and XPH have a correlation of 0.71, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

XPH has higher volatility (8.09%) compared to FBT (6.29%). In terms of maximum drawdown, FBT dropped -40.51% vs XPH's -48.03%.

On 10-year performance, FBT leads with 9.39% vs 4.97% for XPH. On fees, XPH is cheaper at 0.35% per year. On volatility, FBT has been the lower-risk option at 6.29%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 10-year period, FBT has performed better with a 9.39% return vs 4.97%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

XPH is cheaper with a 0.35% expense ratio, compared with 0.57% for FBT.

XPH has the higher dividend yield at 0.49%, compared with 0.00% for FBT.

FBT tracks NYSE Arca Biotechnology Index, while XPH tracks S&P Pharmaceuticals Select Industry Index. They also come from different issuers: First Trust and State Street. Their fees differ too: 0.57% for FBT and 0.35% for XPH.

XPH currently has the higher Sharpe Ratio (2.95 vs 2.31), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for FBT and XPH

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer